Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Jacob deGrom

Jacob deGrom Dealing With Back Tightness

By | at

Mets ace Jacob deGrom departed the team’s instrasquad game after one inning Tuesday because of back tightness, Tim Healey of Newsday tweets.

It’s not yet clear whether this issue will jeopardize deGrom’s chances of taking the ball for the Mets when their season opens July 24. As Tim Britton of The Athletic points out, though, back tightness did prevent deGrom from making an Opening Day start in 2018.

If the Mets are going to break their three-year playoff drought in 2020, it stands to reason they’ll need a healthy deGrom continuing to lead their pitching staff. The 32-year-old is irreplaceable, having won back-to-back National League Cy Youngs and consistently provided front-line production since he debuted in the majors in 2014. He fired 204 innings of 2.43 ERA/2.67 FIP ball with 11.25 K/9 and 1.94 BB/9 last year.

Of course, with righty Noah Syndergaard out for the year after undergoing Tommy John surgery, deGrom is all the more important to the Mets’ cause. Marcus Stroman, Rick Porcello, Steven Matz and Michael Wacha are slated to make up the rest of what should be a solid rotation if healthy, but the Mets’ depth looks questionable (Walker Lockett and Corey Oswalt may be first in line for starts in the event of an injury).

East Notes: Moose, Jays, Donaldson, Braves, N. Walker, deGrom

By | at

Mike Moustakas came off the market when he signed a surprisingly large contract (four years, $64MM) with the Reds in December. It turns out that the Blue Jays were among the runners-up for Moustakas, per MLB Network’s Jon Heyman, who tweets that they made him a three-year, $30MM offer. The Reds obviously blew that proposal out of the water, however, and the Jays pivoted to a much cheaper corner infielder Travis Shaw (one year, $4MM). A third baseman for most of his career, Moustakas is set to handle second in Cincinnati. That position is spoken for in Toronto (Cavan Biggio), as is third (Vladimir Guerrero Jr.), so it seems likely Moustakas would have worked at 1B extensively for the first time in his career had the club won the bidding for him. Instead, the Blue Jays will hope for a bounce-back season from Shaw, who was teammates with Moustakas in Milwaukee last year.

Let’s move over to the NL East…

  • The Braves lost their top free agent, Josh Donaldson, to the Twins’ four-year, $92MM offer over the winter. Braves general manager Alex Anthopoulos acknowledged afterward that the team put forth an offer that came up short. Heyman has some details on it, reporting that the Braves were willing to go to four years in the range of $75MM to $90MM to retain Donaldson. That’s a wide gap, so it’s unknown just how much money Donaldson would have left on the table to re-sign with Atlanta. Regardless, the club now looks to be in much less impressive shape at third, where Austin Riley and Johan Camargo are competing for the starting role.
  • Infielder Neil Walker signed a minor league contract with the Phillies over the winter, but he has no plans to play below the MLB level. “I’m not going to concede to the notion of retiring as a 34-year-old who is in good shape,” Walker told Matt Gelb of The Athletic (subscription link). “But I’m not going to play in Triple A.” For now, Walker’s continuing to compete for a reserve role in Philadelphia, but if he’s unable to find a big league job with the Phillies or another team this season, it’s possible it’ll be the end of the line for the longtime second baseman. The switch-hitting Walker did still have something to offer at the plate last season, though, as he batted .261/.344/.395 (99 wRC+) in 381 trips.
  • As a back-to-back Cy Young winner, it doesn’t seem that Mets right-hander Jacob deGrom has to change anything. But the ace is now working on adding more curveballs into his repertoire, Deesha Thosar of the New York Daily News writes. According to FanGraphs, deGrom’s usage of the pitch ranged from 7.9 percent to 10.8 percent from 2014-18. The number dropped to 3 percent in 2019, when opposing hitters had their way with it to the tune of a .364 weighted on-base average. That was the only pitch deGrom threw last year that hitters could even muster a .300 mark against. He was dominant overall, notching a 2.43 ERA/2.67 FIP with 11.25 K/9 and 1.94 BB/9 over 204 innings.

Jacob deGrom, Justin Verlander Named Cy Young Winners

By | at

6:28pm: The BBWAA announced a slight correction in the NL voting (Twitter link), revealing that Ryu finished in second place alone — not in a tie with Scherzer, who is alone in third place. Flaherty is now alone in fourth place as well, with Strasburg landing fifth.

5:56pm: Mets right-hander Jacob deGrom and Astros righty Justin Verlander have been named the Cy Young Award winners in their respective leagues, the Baseball Writers Association of America announced Wednesday (click for voting breakdowns in the National League and American League).

It’s the second consecutive Cy Young win for deGrom, who has cemented himself among the elite arms of the generation. The 31-year-old deGrom received 29 of a possible 30 first-place votes, with the Dodgers’ Hyun-Jin Ryu receiving the lone other first-place vote. Ryu, who narrowly topped deGrom for the NL ERA title but tossed 22 fewer innings, finished in a second-place tie with Max Scherzer. Stephen Strasburg and Jack Flaherty, meanwhile, were only slightly behind that pair in a fourth-place tie of their own. Mike Soroka, Sonny Gray, Clayton Kershaw, Walker Buehler, Kirby Yates and Patrick Corbin all received votes and appeared further down the ballot.

Tossing 200 innings is an increasingly rare feat in today’s era of bullpen dominance, but deGrom delivered his third straight year of 200-plus frames, finishing with 204 innings of 2.43 ERA ball. His 2.67 FIP largely supported that excellent ERA, and deGrom was once again masterful in terms of overall strikeout percentage (31.7 percent) and walk percentage (5.5 percent). The right-hander, to this point, hasn’t given the Mets any reason to second-guess the four-year, $120.5MM contract extension they awarded him prior to the 2019 campaign. That pact ensured that deGrom will be a fixture on the starting staff for years to come, and he’ll join Noah Syndergaard, Steven Matz and Marcus Stroman in a formidable top four in 2020 as the Mets look to reload and once again take aim at a postseason berth.

Verlander, 36, narrowly edged out teammate Gerrit Cole but managed to secure his second career Cy Young win. No pitcher outside of Verlander or Cole received a first- or second-place vote, but Verlander’s 17 first-place votes won the day. Rays star Charlie Morton received the bulk of the third-place votes (18) and came in third place on the ballot, while Cleveland’s Shane Bieber received 10 third-place votes and finished fourth in voting. Lance Lynn parlayed his brilliant rebound campaign into a fifth-place finish, while Eduardo Rodriguez, Lucas Giolito and Mike Minor rounded out the ballot (in that order).

Verlander led the Majors with 223 innings pitched and finished second in the game in strikeout percentage (35.4 percent), trailing only Cole (39.9 percent) in that regard. Verlander’s 2.58 ERA was slightly higher than Cole’s 2.50 mark, and his FIP (3.27) was a good margin higher than that of Cole (2.64). But Verlander yielded fewer walks in more innings pitched, started one more game than Cole and finished the year with 21 victories to Cole’s 20. The two were widely expected to crush the rest of the field in a tightly contested race and did just that. Verlander would have been a free agent alongside Cole were it not for the two-year, $66MM extension he signed over the winter. He’ll instead join Zack Greinke atop the Houston rotation for the next couple of seasons as he seeks to add a third trophy to his Cooperstown case.

Trade Candidates: Top 5 Starters By K/BB Ratio

By | at

If you’re a pitcher, there aren’t many more important skills than racking up strikeouts and limiting walks. The on-the-block starters who have been adept in both categories in 2019 figure to be among the players who garner the most interest from other teams leading up to the July 31 trade deadline. With help from the trade candidates list MLBTR’s Jeff Todd and Steve Adams assembled last week, here’s a look at the five qualified, potentially movable starters who have stood out more than the rest in the K/BB department this year…

Zack Greinke, RHP, Diamondbacks: K/BB ratio: 7.13

  • Even though he’s 35 years old and has a fastball that clocks in just below 90 mph, Greinke remains one of the majors’ preeminent starters. Greinke has fanned 8.02 batters per nine this year and walked a paltry 1.13, helping him to a 2.95 ERA/3.20 FIP across 128 frames. Plus, in a game where home runs are becoming more prevalent, Greinke has yielded under one per nine. If the Diamondbacks go into sell mode, Greinke is theoretically someone who’d draw plenty of interest. However, his contract could serve as a major roadblock. Not only is Greinke owed roughly $79MM through 2021, but his partial no-trade clause gives him the right to say no to 15 teams.

Matthew Boyd, LHP, Tigers: K/BB ratio: 6.33

  • A glance at Boyd’s MLBTR page shows no shortage of teams in pursuit of the breakout 28-year-old, who has evolved into a K/BB master this season. Boyd has struck out 12 per nine and issued just 1.89 BB/9 at the same time, though a low groundball percentage (37.1) has played in a part in recent difficulties preventing home runs. Boyd has allowed 10 in seven starts dating back to the beginning of June, when he owned a 3.01 ERA. He has now posted a 3.95 mark in 114 innings this year, albeit with a 3.47 FIP/3.35 xFIP and the majors’ 11th-highest swinging-strike rate (14 percent). Considering Boyd’s 2019 production, his $2.6MM salary and his three remaining seasons of arbitration control, it’s no wonder teams are lining up for him.

Jacob deGrom, RHP, Mets: K/BB ratio: 5.14

  • Despite their awful 42-51 record, the Mets probably aren’t going to trade deGrom, the reigning NL Cy Young winner whom they signed to a four-year, $120.5MM extension entering the season. The 31-year-old hasn’t been the otherworldly force he was in 2018, but that’s far more of a compliment to his work a season ago than a knock on what he has done in 2019. To this point, deGrom has pitched to a sparkling 3.21 ERA/3.12 FIP with 11.27 K/9 and 2.19 BB/9 over 115 innings. Should the Mets at least consider trading him? Many of you think so, but general manager Brodie Van Wagenen’s unlikely to pull the trigger.

Madison Bumgarner, LHP, Giants: K/BB ratio: 4.84

  • It’s true Bumgarner isn’t the ace he was in his halcyon days, but the 29-year-old’s K/9 (9.33) and BB/9 (1.93 BB/9) are befitting of a front-line arm. His 3.86 ERA and 3.80 FIP tell another story, though they’re certainly not subpar. The multi-time playoff hero has drawn tons of interest in advance of the deadline, and is likely the top rental starter in the rumor mill. For a while, Bumgarner has looked like a surefire trade candidate for the Giants, but a recent hot streak has put them just three games back in the National League’s wide-open wild-card race. Still, odds are that they’ll move Bumgarner for a solid return in the next two weeks.

Mike Leake, RHP, Mariners: K/BB ratio: 4.72

  • Leake’s inclusion on this list comes as a surprise in light of the other hurlers on it, and he’s definitely not part of it because of an impressive strikeout total. To the contrary, Leake has fanned a meager 6.63 batters per nine over 115 1/3 frames. On the other hand, his 1.4 BB/9 is outstanding. The same can’t be said for Leake’s 4.60 ERA/4.99 FIP or his 88.2 mph average fastball velocity, though. As a back-end starter who’s owed the balance of $36MM through 2020 (including $9MM from his prior team, the Cardinals, and a $5MM buyout in 2021), there isn’t much trade value here despite Leake’s placement in this top five.

MLBTR Poll: Should Mets Entertain Offers For Jacob deGrom?

By | at

In an interesting examination, Joel Sherman of the New York Post makes the case that the Mets ought to take offers on ace Jacob deGrom. He doesn’t exactly advocate a swap — the club ought to move him only “if the return is so overwhelming that they can’t say no,” in Sherman’s estimation — but does suggest it’s a realistic possibility worth pursuing.

That’d be quite an about-face given that deGrom only just inked an extension with the New York organization over the offseason. It really doesn’t kick in until after the present season. Nominally a four-year, $120.5MM pact, the value of the extension was reduced significantly by deferrals.

That is a lot of coin for a pitcher who recently reached his 31st birthday, though deGrom is not just any hurler. He hasn’t been as dominant as he was last year, but that’s due mostly to regression in the home run department and a few shifts in sequencing fortune. Through 110 innings, he carries a 3.27 ERA with 11.3 K/9 and 2.1 BB/9. All the skills remain evident: deGrom has actually boosted his average fastball velocity to over 97 mph and is maintaining a swinging-strike rate in range of 15%.

There are some obvious barriers to a deal, as Sherman notes, beginning with Mets ownership. Even if the Wilpons are willing to authorize a franchise-altering swap, deGrom would have his say given his full no-trade rights.

That doesn’t mean it isn’t fascinating to consider the possibilities. At the moment, this year’s trade market is led by decidedly less-valuable hurlers such as Madison Bumgarner (who hasn’t lived up to his storied past of late), Marcus Stroman (often excellent but not consistently dominant), and deGrom’s teammate Zack Wheeler (ditto). deGrom is unquestionably one of the game’s very best pitchers; controlling him for four years at big but not eye-watering money would hold plenty of appeal.

There’s certainly some sense in the notion that the Mets ought to be willing to hit the re-set button. The offseason moves of new GM Brodie Van Wagenen have not hit the mark thus far; neither did those of his predecessor Sandy Alderson in the winter prior. Keeping deGrom while dealing only rental pieces would presumably mean a third-straight offseason re-tooling effort on the heels of a disappointing season.

On the other hand, the Mets would find themselves in a funny spot without deGrom. They still owe big money to players such as Yoenis Cespedes, Robinson Cano, Jed Lowrie, Wilson Ramos, and Jeurys Familia. They’ll be paying another arb raise to Noah Syndergaard, unless he’s also made available. (That would arguably make quite a bit of sense, whether or not deGrom is shopped; perhaps the underperforming Thor deserves his own poll.)

The situation obviously does not admit of straightforward solutions. How do you think the Mets should handle it? (Poll link for app users.)

What Should the Mets Do With Jacob deGrom This Summer?
Dangle him but only move him for a huge return. 52.98% (6,420 votes)
Don't even think about it! 23.73% (2,875 votes)
Trade him for the best offer they can get. 23.29% (2,822 votes)
Total Votes: 12,117

Mets Place Justin Wilson On 10-Day IL; MRI Clean For DeGrom

By | at

The Mets announced today that they’ve placed southpaw reliever Justin Wilson on the 10-day injured list, as Tim Britton of The Athletic was among those to cover (Twitter links). He’s experiencing elbow soreness, but the club indicated it anticipates a brief IL stint after receiving the results of an MRI.

The imaging gods are shining on Queens, it seems. Ace starter Jacob deGrom’s MRI came back negative, so his elbow scare appears to be just that. deGrom was able to throw a pen session earlier today; it seems likely he’ll be ready for activation at or near the 10-day minimum.

A few other roster tweaks are also in the books. The Mets activated third baseman Todd Frazier, as anticipated, and called up infielder Luis Guillorme. (Guillorme boosts the infield depth further with both Robinson Cano and Amed Rosario dealing with minor issues.) To create an additional active roster spot, the Mets optioned down righty Paul Sewald.

Wilson’s absence leaves a notable hole in the New York pen — though the hope is it’s only a temporary one. Wilson has thrown 8 1/3 useful innings to open the year, allowing three earned runs on six hits with eight strikeouts and four walks. There are two other southpaws available in Luis Avilan and Daniel Zamora, but the former has been torched while the latter hasn’t yet pitched in the bigs this season.

Injury Notes: deGrom, Cano, Scherzer, Dodgers, Blue Jays, Sanchez

By | at

Following a recent elbow scare, Mets ace Jacob deGrom may not be headed for an MRI after all, according to Newsday’s Tim Healey. After being scratched from his most recent start and placed on the 10-day injured list with elbow soreness, deGrom was able to play catch on Saturday, with the pitcher saying that he felt “completely normal.” DeGrom cited his illness, which prevented him from maintaining his usual routine throughout last week, as the primary source of his soreness. Both deGrom and manager Mickey Callaway expressed little concern over the soreness, leading the Mets to reconsider the previous plan to schedule an MRI for Monday. To be sure, that remains on the table, as doctors will continue to monitor the 2018 Cy Young Award winner; however, the organization has expressed confidence that additional imaging will not be necessary, and deGrom has stated that he intends to start on Friday, when he can be activated from the IL.

Here’s the latest on other injuries from around baseball…

  • DeGrom’s teammate Robinson Cano exited Sunday’s matchup with the Cardinals after he was hit in the hand with an Andrew Miller pitch. X-rays returned negative results, but Healey notes that Cano was wearing a cast after the game and will likely undergo further testing to determine the seriousness of the injury. Off to a slow start with his new club, Cano certainly does not need an injury to complicate an already challenging April.
  • Nationals ace Max Scherzer suffered an unusual injury earlier today when he tweaked his left intercostal while dodging a foul ball that found its way to the Nats’ dugout. Per Byron Kerr of MASN, Scherzer is optimistic that the injury will only keep him out of commission for a couple of days and will not require an IL stint. Scherzer started Saturday’s game in Miami, so such a time frame would not require the righty to miss any scheduled starts.
  • According to Pedro Moura of The Athletic, the Dodgers will activate southpaw Rich Hill and catcher Russell Martin this weekend when the Pirates visit Dodger Stadium. Both veterans are currently on the 10-day IL, with Martin suffering from lower back inflammation and Hill, who has yet to make his 2019 debut, recovering from a left knee sprain. The Dodgers’ rotation has excelled even without Hill, but the club will certainly welcome the 38-year-old back into the fold, further strengthening the pitching staff.
  • Bad news for the Blue Jays’ rotation continues to pile up, with right-hander Aaron Sanchez exiting Sunday’s game due to a broken fingernail on his right middle finger. Notably, Sanchez has a history of finger issues, which have led to IL stints in each of the previous two seasons. However, manager Charlie Montoyo told Ben Nicholson-Smith of Sportsnet (Twitter link) that he is hopeful the injury will not force Sanchez to miss any starts.

Jacob deGrom Headed For Elbow MRI, Injured List

By | at

6:01pm: Mets GM Brodie Van Wagenen announced to reporters that deGrom is going on the injured list, retroactive to April 16th. (Via Joel Sherman of the New York Post; links to Twitter.) Van Wagenen says that deGrom has been disrupted by an illness, seemingly implying that is as much a factor here as the arm issue. The hurler is said to be dealing only with mild soreness that has already improved, with the imaging being classed a precautionary measure. The expectation at this point, per Van Wagenen, is that deGrom will be activated to start on April 26th.

4:20pm: Mets ace Jacob deGrom is headed to New York to undergo an MRI on his right elbow, manager Mickey Callaway told reporters including Tim Healey of Newsday (Twitter link). That’s less than welcome news for a team that is already dealing with some struggles in its vaunted rotation.

Given that deGrom has yet to undergo a full medical examination, there’s no reason to jump to any conclusions here. It’s plenty possible that there’s no real issue whatsoever. All we know at present is that the club felt it worthwhile to send him in for a checkup after his elbow was “barking” today after he played catch in advance of his scheduled start tomorrow.

deGrom last pitched on the 14th, throwing 114 pitches but lasting just five innings. He didn’t exhibit any velocity issues; to the contrary, he has dialed up the heat over the course of the season. Though his last two outings have not been his best, there hasn’t been any indication of a problem before today’s news.

The hope, clearly, is that the reigning National League Cy Young winner is just experiencing a minor issue. He’ll surely be handled with care regardless, as the Mets can ill afford to allow a small problem to become a larger one. deGrom, who inked a four-year extension just before the start of the season, has previously undergone Tommy John surgery but has been quite durable since.

Mets Extend Jacob deGrom

By | at

TODAY: The deal includes $52.5MM in deferred money, all without interest, Jon Heyman of MLB Network reports (Twitter links). $12MM in 2020, $13.5MM in 2021, $15MM in 2022, and $12MM in 2023 will all be pushed to the future. There’ll also be a $15MM deferral on the 2024 option, if it’s picked up.

The deferred money will be pushed back 15 years, per Ron Blum of the AP, which sets up a series of payouts beginning in 2035. Amusingly, and surely not coincidentally, deGrom’s payments will seamlessly take over the slot long occupied by annual payouts to former player Bobby Bonilla, Mike Mayer of Metsmerized notes on Twitter.

Those extensive deferrals clearly reduce the true value of the contract, though the precise amount depends upon what discount rate is utilized. Bob Nightengale of USA Today tweets that the $137.5MM owed to deGrom in the future has been assigned a present-day valuation of $108.9MM, though it’s unclear what basis was used to reach that number.

YESTERDAY, 4:52pm: The Mets have formally announced deGrom’s extension.

“This is a tremendous day for Jacob, his family, our fans and the entire Mets organization,” Mets COO Jeff Wilpon said in the press release announcing the contract. “Last year, Jacob had one of the most remarkable seasons in baseball history and we are excited to be able to reward him. Mets fans can celebrate knowing their ace will remain in Flushing.”

7:36am: The Mets have agreed to terms on an extension with star right-hander Jacob deGrom, according to Andy Martino of SNY.tv (Twitter links). deGrom, the reigning National League Cy Young Award winner, is undergoing a physical today. The contract includes four years and $120.5MM in new money, as Ken Rosenthal of The Athletic first reported (Twitter links), with some of it deferred.

Earlier this year, deGrom agreed to a $17MM arbitration contract for the 2019 season. That effectively remains in place, though it is now restructured as a $10MM signing bonus and $7MM salary, Joel Sherman of the New York Post reports on Twitter. What would have been deGrom’s final arbitration season, 2020, will be locked in at $23MM. He’ll then earn $33.5MM in each of the next two seasons and $30.5MM in 2023 — if he does not first opt out. The option-year value is $32.5MM, ESPN.com’s Jeff Passan tweets.

If indeed a deal is finalized, it’d bring an end to a long-running and rather fascinating saga regarding deGrom’s future. It was just last summer that deGrom’s then-agent, Brodie Van Wagenen, was advocating that the team either work out an extension or trade the ace right-hander. In a cinematic twist, Van Wagenen became the Mets’ general manager last fall, recusing himself from direct extension talks with deGrom while the pitcher chose to remain with the same agency (CAA Baseball). (That recusal concept was evidently of rather limited scope, or has since been modified or waived, as Sherman tweets that Van Wagenen was personally on hand for the final negotiations.)

The sides held preliminary talks at the Winter Meetings, but then a lengthy silent period ensued. After agreeing to a 2019 arbitration salary, which included a record-setting $9.6MM raise, the deGrom camp put an Opening Day deadline on talks, so the clock was ticking. It seemed hopeful as camp opened that a deal would materialize, but the more recent vibe was much less promising. But Andy Martino of SNY.tv tweeted yesterday that talks were still ongoing, with Michael Mayer of MetsMerizedOnline adding on Twitter that there was some forward progress toward a deal.

As it turns out, the sides lined up on a contract that understandably includes some concessions in both directions. deGrom will turn 31 this June and was not set to reach the open market until the conclusion of the 2020 campaign. Compare that to Chris Sale, whose recent extension came just before his 30th birthday and entering his final season of contractual control. (Of course, the lefty was also coming off of an injury-limited second half to the 2018 season.) Sale’s contract provided five seasons and $145MM in new earnings; he’ll pitch the entire final season of that deal at 35 years of age. deGrom receives a slightly higher AAV, even though the first new contract year covers an arb-eligible season, and will celebrate his 35th birthday in the middle of his final guaranteed season (if he hasn’t already opted out).

Both of those outstanding hurlers might have found greater riches in free agency. Sale would’ve been the top arm available this coming winter, while deGrom surely would’ve been among the most desirable free agents of the 2020-21 offseason. Zack Greinke had already turned 32 when he secured a six-year, $206.5MM deal with the Diamondbacks. But that deal seemed an outlier when it was signed and the market has since shifted. Clayton Kershaw hadn’t yet turned 31 and had produced nothing but excellent results when he re-upped with the Dodgers last fall, but settled for a three-year pact after experiencing back issues and peripheral declines.

There’s also ample risk in pitching a full MLB season, so extensions have generally lagged free agency in value to a greater extent than is the case for position players. A few still-youthful hurlers nearing free agency have secured bigger money — Kershaw didn’t quite reach $200MM in his first long-term contract if you deduct his anticipated arbitration salary from that season; Stephen Strasburg secured $175MM over seven new seasons part-way through his final year of team control. But otherwise, the largest pitching extensions have gone to Sale ($145MM), Cole Hamels ($144.5MM), and Justin Verlander ($140MM).

[RELATED: MLBTR Extension Tracker]

For their money, the Mets will secure the services of one of the game’s very best hurlers for most or all of his remaining productive campaigns. Never overly hyped as a prospect, deGrom’s early development was slowed by Tommy John surgery. But he emerged in 2014, earning a call-up to the majors and succeeding beyond any reasonable expectations. While he was never much of a strikeout pitcher in the minors, deGrom steadily maintained about a K per inning in his early seasons. He began ramping that up further in 2017, which was also his first 200-plus-inning campaign, but didn’t really take the next step until last year.

Entering the 2018 campaign, deGrom carried a 2.98 ERA with 9.7 K/9 and 2.3 BB/9 through 680 2/3 career innings. There had been a few health wobbles along the way but he was, by and large, a durable and thoroughly excellent pitcher. It seemed there wasn’t much more ceiling to reach, but he unquestionably found it.

Ramping up his velocity (96.7 mph average fastball) and increasingly shelving his sinker in favor of his two offspeed offerings (change and slider; combined usage of 40%) helped deGrom boost his swinging-strike rate to a career-high 15.1%. He drove his strikeout rate up to a personal-best 11.2 K/9 while maintaining a typically sparkling 1.9 BB/9 walk rate, cut back on the home run issues that had cropped up a bit in 2017, and induced nearly as much soft contact (25.2%) as he allowed hard contact (26.6%).

The results followed those impressive underlying numbers. deGrom finished the 2018 campaign with 217 innings of 1.70 ERA ball. Unsurprisingly, given the off-the-charts earned run outcomes, ERA estimators felt there was a bit of good fortune mixed in — but not enough to detract from deGrom’s excellence. He was credited with 1.99 FIP, 2.60 xFIP, and 2.78 SIERA.

Nothing is assured in this world, least of all when it comes to future pitching performance. But deGrom seems about as good a bet as any veteran hurler to keep producing into his mid-thirties. His ability to maintain top physical form will perhaps dictate the extent to which he can approach his newly established personal heights, but his multi-pitch arsenal and impeccable command seem to provide about as much of a floor as any starter.

The upside in the contract is plainly limited by deGrom’s age, but that doesn’t mean the Mets can’t hope to achieve good value. The organization will still retain a fair bit of payroll flexibility after the 2020 season, the final year of obligations to Yoenis Cespedes and a few other pricey veterans. deGrom knocks Cespedes off of the organization’s financial Mt. Rushmore, joining David Wright, Johan Santana, Carlos Beltran to make up the four largest contracts in Mets history.

Photo courtesy of USA Today Sports Images.

Latest On Extension Talks Between Mets, Jacob deGrom

By | at

There has been a cavalcade of extensions across Major League Baseball this spring, but it doesn’t appear Mets right-hander Jacob deGrom will become the latest star to ink a new deal. Speaking about his future Saturday, deGrom told Anthony DiComo of MLB.com, Tim Healey of Newsday and other reporters that his optimism about signing before his self-imposed Opening Day deadline on March 28 is fading.

As recently as March 13, the reigning National League Cy Young winner seemed hopeful about landing a long-term pact by the opener. But deGrom said Saturday he’s “probably not as [optimistic]” an agreement between his camp and the Mets will materialize in time for the season. At that point, the 30-year-old will be more concerned about on-field matters.

“I don’t know where it’s going to end up,” deGrom said. “I’ve really not been trying to think about it. Yeah, I said I wanted to get something done, but it’s getting close to Opening Day and I think my focus is on that right now.”

While talks haven’t gone to his liking, they’re still ongoing, according to deGrom, who again noted he’d like to remain with the Mets. That being the case, it seems there’s still hope they’ll reach an 11th-hour deal. To this point, though, the Mets have reportedly been leery of committing a sizable payday to deGrom – who, despite the brilliance he has displayed since debuting in 2014, doesn’t have all the leverage here. After all, not only is deGrom on the wrong side of 30, but he’s a past Tommy John surgery recipient whom the Mets aren’t at risk of losing to free agency until after the 2020 campaign. Conversely, fellow veteran aces Chris Sale and Justin Verlander were only a year from free agency when they signed extensions this week, thereby increasing their teams’ urgency to lock them up.

Asked if he’s comparable to Sale, whom the Red Sox awarded a five-year, $145MM guarantee, deGrom said: “I don’t know. He’s a little bit closer to free agency. I’d have to sit down with my agents again and go over some things to really fully understand where we’d like to be.” 

Last July, as deGrom was amid a season for the ages, his former agent, Brodie Van Wagenen, implored the Mets to either trade the ace or extend him. The Mets didn’t oblige in either case, though they did make the outside-the-box decision in October to hire Van Wagenen as their general manager. Van Wagenen entered into the position with keen insight into deGrom’s circumstances, then, and as a former bigwig at CAA Sports, he’s familiar with the hurler’s new representatives, Jeff Berry and Matt Ricatto. Nevertheless, the parties haven’t been able to hammer anything out, and if deGrom’s deadline holds, they’ll either wait until next offseason to revisit contract talks or table them altogether. By then, deGrom could be heading into his final winter of arbitration eligibility. He and the Mets avoided the arbitration process this past January by agreeing to a record-setting $17MM salary for 2019.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top